Revolution Medicines, Inc. (RVMD)
RVMD price $192.62 -1.66 -0.85%
- Ticker
- RVMD
- Price
- $192.62
- Change
- -1.66 -0.85%
- Market cap
- $41.29B
- P/E
- -21.93
- Forward P/E
- 37.53
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 53
Revolution Medicines, Inc. is a precision oncology firm operating in the clinical development stage, dedicated to creating innovative treatments that target novel pathways crucial for RAS-driven cancers. Its pipeline includes several promising drug candidates: RMC-4630, an SHP2 inhibitor, is currently undergoing Phase 1/2 clinical trials for various solid tumors, such as gynecological and colorectal cancers. The…